Kraig Biocraft Laboratories Develops Artificial DNA Constructs for New Class of High Strength Fibers

Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced that the Company, working in cooperation with leading laboratories, is synthesizing DNA sequences and genetic constructs for its second generation of advanced spider silk based polymers.

The artificial DNA constructs which the company is creating were specifically developed with the technical textiles market in mind.

"These new designer DNA sequences are being rolled out as a part of our plan to build on our recent success by creating new materials and new products," said Kraig's CEO Kim Thompson. "These new genetic constructs are being created right now, for use in the production of a new class of high performance fibers. We are developing this next generation of genetically modified silk fibers specifically to capture a share of the technical textiles market. This is the primary market for high strength fibers and is currently estimated at $120 billion. We believe that these revolutionary materials will have tremendous potential in the technical textiles marketplace for high strength fibers."

"High strength designer fibers have the potential to satisfy the multi-billion dollar demand for new materials with tremendous strength-to-weight ratios," Thompson continued. "Based upon what we learned in the process of developing our first generation of revolutionary fibers, we believe that these second generation designer DNA sequences have the potential to significantly increase raw strength-to-weight ratios."

Kraig Biocraft Laboratories recently announced its scientific and commercial breakthrough in producing genetically engineered (recombinant) spider silk in a scalable and cost effective platform. The biotechnology company is a leader in the development of genetic engineering technologies with applications for the global textile markets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.